Tenax Therapeutics Inc (TENX)
3.14
-0.06
(-1.88%)
USD |
NASDAQ |
Jun 14, 16:00
3.18
+0.04
(+1.27%)
After-Hours: 20:00
Tenax Therapeutics Total Liabilities (Quarterly): 2.031M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 2.031M |
| December 31, 2023 | 3.586M |
| September 30, 2023 | 0.6022M |
| June 30, 2023 | 0.8238M |
| March 31, 2023 | 0.9939M |
| December 31, 2022 | 1.912M |
| September 30, 2022 | 0.7852M |
| June 30, 2022 | 1.572M |
| March 31, 2022 | 2.131M |
| December 31, 2021 | 1.748M |
| September 30, 2021 | 1.673M |
| June 30, 2021 | 1.414M |
| March 31, 2021 | 1.465M |
| December 31, 2020 | 2.243M |
| September 30, 2020 | 1.593M |
| June 30, 2020 | 2.324M |
| March 31, 2020 | 2.536M |
| December 31, 2019 | 2.593M |
| September 30, 2019 | 1.238M |
| June 30, 2019 | 1.044M |
| March 31, 2019 | 1.117M |
| December 31, 2018 | 1.566M |
| September 30, 2018 | 0.5162M |
| June 30, 2018 | 0.7928M |
| March 31, 2018 | 0.311M |
| Date | Value |
|---|---|
| December 31, 2017 | 1.009M |
| September 30, 2017 | 0.8386M |
| June 30, 2017 | 2.183M |
| March 31, 2017 | 5.041M |
| December 31, 2016 | 6.199M |
| September 30, 2016 | 13.02M |
| June 30, 2016 | 13.24M |
| March 31, 2016 | 14.21M |
| October 31, 2015 | 11.52M |
| July 31, 2015 | 11.22M |
| April 30, 2015 | 12.48M |
| January 31, 2015 | 10.83M |
| October 31, 2014 | 11.64M |
| July 31, 2014 | 9.858M |
| April 30, 2014 | 10.54M |
| January 31, 2014 | 3.635M |
| October 31, 2013 | 1.509M |
| July 31, 2013 | 4.759M |
| April 30, 2013 | 4.959M |
| January 31, 2013 | 4.643M |
| October 31, 2012 | 3.600M |
| July 31, 2012 | 5.768M |
| April 30, 2012 | 4.488M |
| January 31, 2012 | 6.762M |
| October 31, 2011 | 8.274M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.6022M
Minimum
Sep 2023
3.586M
Maximum
Dec 2023
1.715M
Average
1.633M
Median
Total Liabilities (Quarterly) Benchmarks
| CEL-SCI Corp | 15.74M |
| AIM ImmunoTech Inc | 11.36M |
| IGC Pharma Inc | 2.206M |
| NovaBay Pharmaceuticals Inc | 5.197M |
| Protalix BioTherapeutics Inc | 60.04M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 14.46M |
| Shareholders Equity (Quarterly) | 12.43M |